First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial.
Braulke F, Zettl F, Ziepert M, Viardot A, Kahl C, Prange-Krex G, Korfel A, Dreyling M, Bott A, Wedding U, Reichert D, de Wit M, Hartmann F, Poeschel V, Schmitz N, Witzens-Harig M, Klapper W, Rosenwald A, Wulf G, Altmann B, Trümper L.
Braulke F, et al. Among authors: wedding u.
Hemasphere. 2022 Dec 1;6(12):e808. doi: 10.1097/HS9.0000000000000808. eCollection 2022 Dec.
Hemasphere. 2022.
PMID: 36479544
Free PMC article.